Association study of common genetic variants in pre-microRNAs in patients with ulcerative colitis

Masaaki Okubo1, Tomomitsu Tahara, Tomoyuki Shibata

  • 1Department of Gastroenterology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi 470-1192, Japan.

Abstract

Insights

Single-nucleotide polymorphisms (SNPs) in microRNAs (miRNAs) may influence ulcerative colitis (UC) risk and disease severity. Specifically, the rs3746444 SNP is linked to UC susceptibility and more severe disease phenotypes in a Japanese population.

Area of Science:

  • Genetics
  • Gastroenterology
  • Molecular Biology

Background:

  • Single-nucleotide polymorphisms (SNPs) in microRNAs (miRNAs) are implicated in various human diseases.
  • Investigating specific miRNA SNPs can reveal associations with inflammatory bowel diseases like ulcerative colitis (UC).

Purpose of the Study:

  • To evaluate the association of three pre-miRNA SNPs (rs11614913, rs2910164, rs3746444) with ulcerative colitis (UC) risk.
  • To determine if these SNPs influence the clinical and pathological features of UC in a Japanese population.

Main Methods:

  • Genotyping of rs11614913, rs2910164, and rs3746444 SNPs in 170 UC patients and 403 healthy controls.
  • Statistical analysis using odds ratios (OR) and 95% confidence intervals (CI) to assess associations.

Main Results:

  • The rs3746444 AG genotype was significantly associated with increased UC risk (OR=1.51, p=0.037).
  • This genotype correlated with older age at onset, specific colitis types (left-sided, pancolitis), increased hospitalizations, steroid dependence, and refractory disease.
  • The rs11614913 TT genotype was linked to a higher risk of refractory UC phenotypes (OR=2.21, p=0.016).

Conclusions:

  • The rs3746444 SNP is the first identified genetic factor potentially influencing susceptibility to ulcerative colitis.
  • Both rs3746444 and rs11614913 SNPs may play a role in the pathophysiological characteristics and clinical manifestations of UC.

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...